News

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...
Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...
Dr. Jason Rivers, MD, FRCPC, discusses psoriasis symptoms and treatments.
Menthol is extracted from mint plants, creating a cooling sensation and providing temporary relief through counter-irritation ...
The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...
The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and ...
BELLY fat increases your risk of the skin condition psoriasis, a study warns. Psoriasis, which affects one in 50 people – ...
Users call it “without a doubt the best sunscreen I have ever used ,” and “a must-have in my middle-aged skincare routine,” ...
Pack your diet with vitamin C -rich foods. Vitamin C is essential for collagen production to help keep your skin supple and ...
How does one live with psoriasis? From medication to nutrition (and beyond), Olivia Marks goes in search of clear answers.